HYPER-CARDIO: Hyperoxia and Pulmonary Complications After Cardiac Surgery
Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT04278066
Collaborator
(none)
300
1
7
42.9
Study Details
Study Description
Brief Summary
The main objective is to demonstrate that hyperoxia in cardiac surgery increase the occurrence of post-operative pulmonary complications
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
300 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Hyper-Cardia Study : Hyperoxia and Pulmonary Complications After Cardiac Surgery
Actual Study Start Date
:
Feb 5, 2020
Actual Primary Completion Date
:
Sep 5, 2020
Actual Study Completion Date
:
Sep 5, 2020
Outcome Measures
Primary Outcome Measures
- Retrospective study of the average of per and postoperative PaO2 in cardiac surgery [iles analyzed retrospectily from January 1st, 2015 to December 31, 2019 will be examined]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
-
Adult patient (≥18 years old)
-
Patient operated heart surgery with extra-corporal life support
-
Hospitalization in Cardiology intensive and critical care unit
-
Patient operated in HUS between 01/01/2015 and 31/12/2019
-
Subject consent, after information, to the reuse of its data for the purposes of this study
Exclusion Criteria:
-
Non-consent patient
-
Hypoxemic patient
-
Emergency surgery
-
Patient with post-operative cardiac assist device
-
Patient with guardianship
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Service d'Anesthésiologie - NHC | Strasbourg | France | 67091 |
Sponsors and Collaborators
- University Hospital, Strasbourg, France
Investigators
- Study Director: François FISCHER, MD, University Hospital, Strasbourg, France
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT04278066
Other Study ID Numbers:
- 7655
First Posted:
Feb 20, 2020
Last Update Posted:
Oct 7, 2021
Last Verified:
Feb 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Strasbourg, France
Additional relevant MeSH terms: